Business Strategy for Pharmaceuticals/Drugs in China

The market for pharmaceuticals in China is approximately $37 billion.

Western pharmaceutical/drug companies are using multiple business strategies in China today. While a number of foreign manufacturers are selling or planning to sell their drugs and pharmaceuticals in China, others are sourcing/manufacturing, doing R+D, and performing clinical trials. Should a foreign drug company set up a representative office, branch office, joint venture, or wholly foreign-owned enterprise (WFOE) in China today?

Let PBM help you with your China pharmaceutical business strategy.

PBM will study the various opportunities for your pharmaceutical/drug products and come up with the best strategy for you.

For more information on developing your China business strategy, please see the following PBM publications and/or contact us to discuss your specific needs.

China Pharmaceutical Regulatory Report 2011 (publication for sale)
China Pharmaceutical Market Report 2011 (publication for sale)
China Distribution for Medical Devices/Drugs/OTC Products (webcast for sale)
Strategies for Success in China, Japan, and India (webcast for sale)
Managing Asian Cultural Diversity: Cross-Cultural Issues in Asia (webcast for sale)
Changing Business Practices in the Chinese Pharmaceutical Market
Business and Marketing Strategy for China's Pharmaceutical Market (webcast for sale)
How To Do Business in China (PDF)
Entering China's Medical Marketplace